VIV options traders have shifted sharply toward protection. The put/call ratio hit 1.78 on May 21 — nearly 3 standard deviations above the 20-day mean of 0.75 — as the stock has fallen roughly 15% in May alone.
The options shift is stark. Through most of April and into early May, VIV's PCR held steady below 0.60. Then it broke. On May 18 it jumped to 1.42. By May 21 it reached 1.78 — the highest reading in the tracked 20-day window.
That's a near-tripling of the ratio in less than a week. Put buyers are paying up for downside protection at a rate that dwarfs recent norms.
The timing matters. Telefônica Brasil reported Q1 earnings on May 11 and 12. The stock dropped 5.3% on the day and fell a further 9.7% over the following five days. The options market is now pricing in more pain ahead. Next earnings are scheduled for July 28.
The lending market is sending a secondary signal. Cost to borrow has climbed back to 0.90% annually after touching a low of 0.30% in mid-May — a 67% jump in one week and an 83% rise over the past month.
That said, availability remains loose at 449%. For every share already borrowed, more than four remain available in the lending pool. There is no squeeze dynamic here. The CTB uptick looks more like incremental demand from put-buyers hedging positions than a sign of structural short pressure.
Short sellers have actually been retreating. Shares short peaked near 7.75 million in late April. By May 19 they had fallen to 5.28 million — a 32% reduction. The recent week shows a modest 2.6% uptick to 5.5 million, but the trend remains well below early-May levels.
With availability this elevated, the short side is not the primary driver of the current signal cluster. Options traders are leading the defensive repositioning.
Two recent analyst moves cut against the bearish options flow. Scotiabank raised its price target to $15.70 on May 12 — the same day the stock sold off on earnings. Barclays lifted its target to $16.50 in April. Both maintained neutral-leaning ratings. The mean analyst target sits at $11.59, but that figure is anchored to a 2021 data point and may not reflect current views accurately.
Factor scores offer one note of support: VIV's dividend score ranks at the 91st percentile. For income-focused holders, the yield remains a reason to stay.
What to watch: Whether the PCR normalises back toward 0.75 in the days ahead — or continues climbing toward the 52-week high of 16.75 — will signal whether this is a short-term hedge or the start of a more sustained defensive positioning shift ahead of July earnings.
See the live data behind this article on ORTEX.
Open VIV on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
VIV — Telefônica Brasil, the Brazilian telecom giant trading as American Depositary Receipts in New York — reports first-quarter results on May 11. Three signals dominate the setup: a stock drifting lower in a quiet…
